AKBA
Akebia Therapeutics Inc
$1.36
Earnings Summary
Revenue | $56.2Mn |
Net Profits | $0.61Mn |
Net Profit Margins | 1.09% |
Highlights
Akebia Therapeutics Inc’s revenue jumped 1.84% since last year same period to $56.2Mn in the Q4 2023. On a quarterly growth basis, Akebia Therapeutics Inc has generated 33.65% jump in its revenue since last 3-months.
Akebia Therapeutics Inc’s net profit jumped 107.01% since last year same period to $0.61Mn in the Q4 2023. On a quarterly growth basis, Akebia Therapeutics Inc has generated 104.24% jump in its net profits since last 3-months.
Akebia Therapeutics Inc’s net profit margin jumped 106.89% since last year same period to 1.09% in the Q4 2023. On a quarterly growth basis, Akebia Therapeutics Inc has generated 103.17% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Akebia Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.08 |
EPS Estimate Current Year | -0.08 |
Highlights
Akebia Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.08 - a -100% fall from last quarter’s estimates.
Akebia Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.08.
Key Ratios
Key ratios of the Akebia Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Akebia Therapeutics Inc’s earning per share (EPS) jumped 108% since last year same period to 0 in the Q4 2023. This indicates that the Akebia Therapeutics Inc has generated 108% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-14 | -0.04 | 0 | 108% |
2023-11-08 | -0.08 | -0.08 | 0% |
2023-05-08 | -0.15 | -0.14 | 6.67% |
2023-08-28 | -0.02 | -0.06 | -200% |
₹0 US Stocks a/c Opening Fee